SMi is proud to present its 4th annual Allergies conference which returns to London in July 2017 to reflect on the ongoing issues and latest developments in this field.
This year’s event will bring together industry leaders to discuss the latest challenges and changes in the fields of allergen immunotherapy. We will explore novel approaches to treatment, biomarkers and targeted treatments. The challenges to device development and drug delivery will be identified to deepen delegates understanding of the problems relating to these diseases, and discuss the topic of standardisation.
As the prevalence of allergic diseases has increased so has diagnostic technology. Additionally, cutting edge developments in targeted drugs and preventative measures are currently revolutionising the ways in which pharmaceutical and biotech companies are addressing allergies.
Presentations and selected case studies from industry experts on paediatric allergies and immunotherapy, novel approaches to treatment, key decision makers in these fields and unique networking opportunities will make this an event a not to miss opportunity.